Entering text into the input field will update the search result below

Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q1 2021 Results - Earnings Call Transcript

May 04, 2021 11:29 PM ETSangamo Therapeutics, Inc. (SGMO)
SA Transcripts profile picture
SA Transcripts

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2021 Earnings Conference Call May 4, 2021 5:00 PM ET

Company Participants

Aron Feingold - Head of Corporate Communications and Investor Relations Officer

Sandy Macrae - President and Chief Executive Officer

Robert Schott - Senior Vice President and Head of Development

Jason Fontenot - Senior Vice President and Chief Scientific Officer

Mark McClung - Executive Vice President and Chief Business Officer

Bettina Cockroft - Senior Vice President and Chief Medical Officer

Conference Call Participants

Lisa Walter - RBC Capital Markets LLC

Aspen Mori - Bank of America Merrill Lynch

Yanan Zhu - Wells Fargo Securities, LLC

Ritu Baral - Cowen and Company, LLC

Andreas Argyrides - Wedbush Securities Inc.

Boran Wang - Guggenheim Securities, LLC


Good day, and thank you for standing by. Welcome to the Sangamo First Quarter 2021 Teleconference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions]

I would now like to hand the conference over to your speaker today, Aron Feingold, Head of Corporate Communications. Please go ahead.

Aron Feingold

Good afternoon, and thank you for joining us today. With me this afternoon on this call are several members of the Sangamo executive leadership team, including Sandy Macrae, Chief Executive Officer; Mark McClung, Chief Business Officer; Jason Fontenot, Chief Scientific Officer; Rob Schott, Head of Development; and Bettina Cockroft, Chief Medical Officer. Slides from our corporate presentation can be found on our website, sangamo.com, under the Investors and Media section on the Events and Presentations page.

This call includes forward-looking statements regarding Sangamo's current expectations. These statements include, but are not limited to, statements relating to advancing our programs, plans and time lines for enrolling and conducting clinical trials, presenting

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.